Company intelligence / Profile preview

ORIGIO

Ownership: Private
Employees: ~100
Development stage: Other

Overview

ORIGIO develops and supplies a comprehensive range of media, devices, and equipment used in all stages of the IVF process. Their products are widely used globally in fertility clinics for oocyte retrieval, sperm preparation, fertilization support, embryo culture and transfer as well as cryopreservation. The company has established itself as a leader in the ART field with regulatory clearances including CE marking and FDA clearance for key products.

Therapeutic areas: Women's Health
Modalities: DeviceMedia and reagents for IVF proceduresBiologic
Industry: Consumable Medical Devices

Partnerships

No major pharma partnerships reported; integrated within CooperSurgical’s global network

Beyond the preview

Go deeper on ORIGIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ORIGIO.

Explore the full profile